• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (COSTA RICA) STYLE 133PLUS FX TISSUE EXPANDER; EXPANDER, SKIN, INFLATABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (COSTA RICA) STYLE 133PLUS FX TISSUE EXPANDER; EXPANDER, SKIN, INFLATABLE Back to Search Results
Catalog Number 133P-FX-16
Device Problems Improper or Incorrect Procedure or Method (2017); Patient-Device Incompatibility (2682)
Patient Problems Capsular Contracture (1761); Injury (2348)
Event Type  Injury  
Manufacturer Narrative
A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.The event of capsular contracture is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Reason for reoperation: capsular contracture.
 
Event Description
Healthcare professional reported left side capsular contracture baker grade unknown.The device has been explanted.
 
Manufacturer Narrative
A review of the device history record has been completed.No deviations or non-conformances noted.Device evaluation: the device related to the reported event of deflation was received on january 13, 2020 with lot number 2974662.Visual analysis of the returned device identified: one curved opening, black particles in device inner surface and creases.Leak test and microscopic analysis was performed which identified: more than three openings striated.Based on the device analysis the final assessment is: - more than three openings striated assessed as surgical damage.Reason for reoperation: use error.Capsular contractureis a known potential adverse event addressed in the product labeling.
 
Event Description
Additional information received confirmed that the device is a tissue expander which was implanted for longer than 6 months.
 
Manufacturer Narrative
Allergan did not submit this mdr within 30 days of becoming aware.Recent stimulated reporting related to 2011068-7/2/19-001-r has increased complaint and mdr volume.Allergan is implementing a plan to address the increased volumes.
 
Event Description
Healthcare professional reported capsular contracture baker grade iii on left side, device was a tissue expander implanted for more than 6 months.The device has been explanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STYLE 133PLUS FX TISSUE EXPANDER
Type of Device
EXPANDER, SKIN, INFLATABLE
Manufacturer (Section D)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
CS 
MDR Report Key9454525
MDR Text Key170861107
Report Number9617229-2019-20060
Device Sequence Number1
Product Code LCJ
Combination Product (y/n)N
PMA/PMN Number
K143354
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 05/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/11/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/14/2021
Device Catalogue Number133P-FX-16
Device Lot Number2974662
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/13/2020
Date Manufacturer Received02/03/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-